Source: Medthority

TEVA: FDA Accepts Ajovy for Pediatric Migraine

Teva's Ajovy receives FDA filing acceptance for preventing episodic migraines in pediatric patients.

Read full article »
Annual Revenue
$10-50B
Employees
10-50K
Richard Francis's photo - President & CEO of TEVA

President & CEO

Richard Francis

CEO Approval Rating

82/100

Read more